Polycystic Kidney Disease Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney Disease, Adult Intervention: Drug: Lixivaptan Sponsor: Palladio Biosciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials
